0000-0002-1446-2164 About
Distinguished Career of 30+ years as Director/ Lead Scientist / Mentor in Discovery of Emerging Predictive Cancer Biomarkers. Innovative researcher in Translational Oncology with outstanding performance in all phases of Conceptualization, Designing and Implementing Emerging aspects of Pre-clinical Oncology focused on Predictive Cancer Biomarkers, their prospects in Drug Discovery / Targeted Therapeutics including A Newer Paradigm on Tumor-Specific Adjuvant Immunotherapy towards Personalized Cancer Therapy.
Employment
-
ScyTek Labs.Inc. Senior Director( Translational Oncology)2013 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (37)
- Adjuvant Therapy in high risk patients with primary cutaneous melanoma: past, present, and future Save
- Melanoma Vaccines, revisited: a review, update. Save
- Targeting melanoma sites invivo can induce complete tumor ablation and prolong patient's survival. Save
- Aberrant DNA methylation silences the novel heat shock protein H11 in melanoma but not benign melanocytic lesions Save
- CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM) Save
- Stress up-regulates neuronal expression of the herpes simplex virus type 2 large subunit of ribonucleotide reductase (R1; ICP10) by activating activator protein 1 Save
- Overexpression of c-erbB-2 oncoprotein and associated pathobiological factors in invasive primary breast cancer Save
- Distribution of prognostically unfavourable product of c-erbB-2 oncogene and EGF-R in carcinomas of the breast and uterine cervix Save
- Serum lipids, lipoproteins and sex-hormone binding globulin in breast cancer Save
- Status of epidermal growth factor receptors family in hormone-dependent carcinomas of the breast and prostate with reference to serum lipids and lipoproteins Save